Live Breaking News & Updates on Ovishield doses

Stay informed with the latest breaking news from Ovishield doses on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ovishield doses and stay connected to the pulse of your community

CoWIN reconfigured: Covishield second dose appointment after 84 days, existing booking to remain valid

CoWIN reconfigured: Covishield second dose appointment after 84 days, existing booking to remain valid
CoWIN digital portal has been reconfigured to reflect changes in dose interval of Covishield vaccine to 12-16 weeks, said the Health Ministry.
Share
Updated: May 16, 2021, 09:12 PM IST
The Centre on Sunday said that requisite changes have now been made on the CoWIN digital portal, making online or on-site appointments for Covishield vaccine not possible if the period after first dose for a beneficiary is less than 84 days.
The Union Health Ministry said: "CoWIN digital portal has been reconfigured to reflect change in dose interval of Covishield vaccine to 12-16 weeks."

India , Union-territories , Centre-on , Union-health-ministry , Covid-working-group , Serum-institute-of-india , Serum-institute , Cowin , Owin-portal , Accine-appointment , Ovid-vaccine-booking

'Extended gap between 2 doses of Covishield reasonable approach,' says US advisor Dr Fauci

'Extended gap between 2 doses of Covishield reasonable approach,' says US advisor Dr Fauci - "The fact that you delay it that long, it is very unlikely that it would have a negative effect on the efficacy of the vaccine," Fauci said.

New-york , United-states , India , White-house , District-of-columbia , Los-angeles , Anthony-fauci , Department-of-defense , Sputnikv-vaccine , United-state-that , Dr-fauci , Ovishield-vaccine-dose-gap

COVID-19: Government panel recommends 12-16 week gap between Covishield doses, no changes for Covaxin

COVID-19: Government panel recommends 12-16 week gap between Covishield doses, no changes for Covaxin
The National Immunization Technical Advisory Group said pregnant women can choose their vaccine and lactating women will also be eligible for vaccine.
(Image Source: File Photo)
Updated: May 13, 2021, 12:51 PM IST
The National Immunization Technical Advisory Group has suggested that the gap between two doses of the Covishield vaccine can be increased to 12-16 weeks. However, the government panel did not recommend any changes in dosage interval for Covaxin, the second of two vaccines in use in India.
The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield are currently being used in India's inoculation drive against the COVID-19 virus.

India , National-immunization-technical-advisory-group , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunisation , National-technical-advisory-group , National-expert-group , Vaccine-administration , Covid-19-pandemic , Ovid-19-second-wave , Ovid-19-vaccine-above-18 , Accine-doses

Covishield Covid vaccine doses gap extended to 12-16 weeks health ministry latest news update

Covishield, Covishield vaccine doses, Covishield doses, Covishield doses gap, Covishield news, Covishield doses updates, health ministry, covid vaccine doses gap news, vaccine doses gap

India , Bharat , Covishield-covid , Centre-on , Health-ministry , Member-health-niti-aayog , Image-source , Bharat-biotech , National-expert-group , Vaccine-administration , Niti-aayog , Covishield

COVID vaccine data: How many people tested positive after first and second dose?

COVID vaccine data: How many people tested positive after first and second dose?
As per the data, more than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin.
Share
Updated: Apr 21, 2021, 09:45 PM IST
The government on Wednesday shared data of the number of people who tested positive for novel coronavirus after receiving the first and second dose of Covid-19 vaccines - Covaxin and Covishield.
As per the data, more than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin, while over 5,500 contracted the infection after taking the second dose, the Centre said.

Balram-bhargava , Indian-council-of-medical-research , Indian-council , Medical-research , General-balram-bhargava , Covid-19-vaccine , Ovid-19-vaccine-india , Ovid-19-vaccine-news , Ovid-data , Ovaxin-vaccine , Ovishield-vaccine , Cmr

Vaccine shortage in Maharashtra: COVID vaccination halted in Mumbai's BKC centre

Vaccine shortage in Maharashtra: COVID vaccination halted in Mumbai's BKC centre
ANI |
Updated: Apr 20, 2021 13:41 IST
Vaccine shortage in Maharashtra: COVID vaccination halted in Mumbai's BKC centre
Mumbai (Maharashtra) [India], April 20 (ANI): The COVID-19 vaccination drive was temporarily suspended at Mumbai's Bandra Kurla Complex (BKC) vaccination centre due to shortage of vaccines.
Boards reading 'Vaccine out of stock', put up outside BKC vaccination centre.
After the centre ran out of COVID vaccines stock, Mumbai police made an announcement for the general public about the same.
"We had 350-400 Covishield doses, we've administered it. We're awaiting for more doses. Around 2000 Covaxin doses are available for the second dose that is being administered," said Rajesh Dere, Dean of the Centre.

Mumbai , Maharashtra , India , Dean-of-the-centre , Bandra-kurla-complex , Rajesh-dere , Covid-19-vaccination , Umbai , Kc-vaccination-centre , Ovishield-doses , Ovid-19